ZFP Therapeutic

Type: Product
Name: ZFP Therapeutic
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

SANGAMO BIOSCIENCES : Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple...

Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-TBy a News Reporter-Staff News Editor at AIDS Vaccine Week -- Sangamo ... [Published 4 Traders - Sep 17 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Sangamo Biosciences' (SGMO) CEO Edward Lanphier Presents at Morgan Stanley Healthcare Conference (Transcript)

Matthew Palmer - Morgan StanleyGood morning and welcome to the Morgan Stanley Global Healthcare Conference. My name is Matthew Palmer and I am a member of the Biotechnology Equity Research team here at Morgan Stanley. Just before I get started we need ... [Published Seeking Alpha - Sep 10 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Sangamo BioSciences Announces Target Date For First IND For Sangamo's In Vivo ZFN Genome-Editing Platform For Monogenic Diseases

"Shire has been impressed by the rapid progress of the novel hemophilia B program developed by Sangamo," said Albert Seymour"Sangamo's research and development team has succeeded in rapidly advancing the hemophilia B program through small and large animal ... [Published Pettinga Financial Advisors - Sep 10 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T

RICHMOND, Calif., Sept. 8, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new data demonstrating that a single infusion of Sangamo's novel ZFP Therapeutic®, SB-728-T, resulted in sustained reduction and ... [Published PR Newswire: Health - Sep 08 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 3 reports

Sangamo BioSciences Announces Presentation at the 2014 Morgan Stanley Global Healthcare Conference

RICHMOND, Calif. , Sept. 3, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. ( NASDAQ: SGMO ) announced today that Edward Lanphier , Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic ® development programs ... [Published Reliance Trust - Sep 03 2014]
First reported Aug 05 2014 - Updated Aug 06 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference

RICHMOND, Calif., Aug. 5, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president of research and development, will provide an update on the progress of Sangamo's ... [Published PR Newswire: General Business - Aug 05 2014]
First reported Jun 17 2014 - Updated Jun 18 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference

RICHMOND, Calif., June 17, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic® ... [Published PR Newswire: General Business - Jun 17 2014]
First reported Jun 02 2014 - Updated Jun 02 2014 - 2 reports

Sangamo gets CIRM fund to support clinical trial of ZFP Therapeutic for HIVAIDS

Sangamo BioSciences (SGMO) has announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic. ... [Published BioPortfolio - Jun 02 2014]
First reported May 30 2014 - Updated May 30 2014 - 1 reports

Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic® For HIV/AIDS

RICHMOND, Calif., May 30, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City ... [Published PR Newswire: General Business - May 30 2014]
First reported May 29 2014 - Updated May 29 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The Jefferies 2014 Global Healthcare Conference

RICHMOND, Calif., May 29, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ... [Published PR Newswire: General Business - May 29 2014]
First reported May 15 2014 - Updated May 16 2014 - 1 reports

Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference

RICHMOND, Calif., May 15, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president, research and development, will provide an update on the progress of Sangamo's ... [Published PR Newswire: Health - May 15 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

Sangamo BioSciences and Collaborators to Present Data on ZFP Therapeutic Applications and Developments at Annual Meeting of the American Society of Gene and Cell Therapy

RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics® will be presented at the 17th ... [Published PR Newswire: General Business - May 14 2014]

Quotes

...Nichol . "The SB-728-mR-1401 study combines our best understanding, from all of our clinical research, of the potential mechanism of this novel therapeutic and we believe that it will yield data that provide a clear path to pivotal studies."
"Shire has been impressed by the rapid progress of the novel hemophilia B program developed by Sangamo" said Albert Seymour
...Executive Officer of the Mental HealthMental Health AssociationAssociation of Southeastern ... June 2, 2008., "Bill brings to MHASP ... says Denise M Maida, Psy.D , who chairs MHASP,s ..."
NEXT ARTICLE More From BioPortfolio on "Sangamo gets CIRM fund to support clinical trial of ZFP Therapeutic for HIV AIDS"

More Content

All (19) | News (7) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
SANGAMO BIOSCIENCES : Announces Presentation At... [Published 4 Traders - Sep 17 2014]
Sangamo Biosciences' (SGMO) CEO Edward Lanphier... [Published Seeking Alpha - Sep 10 2014]
Sangamo BioSciences Announces Target Date For F... [Published Pettinga Financial Advisors - Sep 10 2014]
Okyanos Cardiac Cell Therapy Clinic Scheduled t... [Published Bio-Medicine - Sep 08 2014]
Sangamo BioSciences Announces Presentation At I... [Published PR Newswire: Health - Sep 08 2014]
Sangamo BioSciences Announces Presentation at t... [Published Reliance Trust - Sep 03 2014]
Sangamo BioSciences Announces Presentation at t... [Published Wall Street Select - Sep 03 2014]
Sangamo BioSciences Announces Presentation at t... [Published PR Newswire: General Business - Sep 03 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Aug 05 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Jun 17 2014]
Sangamo gets CIRM fund to support clinical tria... [Published BioPortfolio - Jun 02 2014]
Sangamo gets CIRM fund to support clinical tria... [Published PBR - News - Jun 02 2014]
Sangamo BioSciences And City of Hope Granted St... [Published PR Newswire: General Business - May 30 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - May 29 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - May 15 2014]
Sangamo BioSciences and Collaborators to Presen... [Published PR Newswire: General Business - May 14 2014]
Sangamo BioSciences Announces Presentations At ... [Published PR Newswire: General Business - May 01 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Feb 26 2014]
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: Health - Feb 06 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Sangamo BioSciences Announces Presentation At I... [Published PR Newswire: Health - Sep 08 2014]
RICHMOND, Calif., Sept. 8, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the presentation of new data demonstrating that a single infusion of Sangamo's novel ZFP Therapeutic®, SB-728-T, resulted in sustained reduction and ...
Sangamo BioSciences Announces Presentation at t... [Published PR Newswire: General Business - Sep 03 2014]
RICHMOND, Calif., Sept. 3, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and ...
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Aug 05 2014]
RICHMOND, Calif., Aug. 5, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Geoff Nichol, M.B., Ch.B., Sangamo's executive vice president of research and development, will provide an update on the progress of Sangamo's ...
Sangamo BioSciences Announces Presentation At T... [Published PR Newswire: General Business - Jun 17 2014]
RICHMOND, Calif., June 17, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Philip Gregory, D.Phil., Sangamo's senior vice president of research and CSO, will provide an update on the progress of Sangamo's ZFP Therapeutic® ...
Sangamo gets CIRM fund to support clinical tria... [Published PBR - News - Jun 02 2014]
Sangamo BioSciences (SGMO) has announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.